 Bank of New York Mellon Corp lifted its stake in Crinetics Pharmaceuticals Inc NASDAQ:CRNX by 3.4 in the 4th quarter, HoldingsChannel reports. The firm owned 35,847 shares of the companys stock after buying an additional 1,183 shares during the quarter. Bank of New York Mellon Corps holdings in Crinetics Pharmaceuticals were worth 899,000 at the ... 